1. Home
  2. RNTX vs FIEE Comparison

RNTX vs FIEE Comparison

Compare RNTX & FIEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNTX

Rein Therapeutics Inc.

HOLD

Current Price

$1.70

Market Cap

42.9M

Sector

Health Care

ML Signal

HOLD

Logo FiEE Inc

FIEE

FiEE Inc

HOLD

Current Price

$7.60

Market Cap

45.6M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNTX
FIEE
Founded
2001
1977
Country
United States
Hong Kong
Employees
10
43
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
42.9M
45.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RNTX
FIEE
Price
$1.70
$7.60
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
118.7K
10.8K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$1.50
52 Week High
$2.22
$7.95

Technical Indicators

Market Signals
Indicator
RNTX
FIEE
Relative Strength Index (RSI) 69.15 66.31
Support Level $1.08 $2.45
Resistance Level $2.18 $7.88
Average True Range (ATR) 0.19 0.21
MACD 0.04 0.01
Stochastic Oscillator 83.78 89.91

Price Performance

Historical Comparison
RNTX
FIEE

About RNTX Rein Therapeutics Inc.

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.

About FIEE FiEE Inc

FiEE Inc, formerly Minim Inc is a digital service provider focused on integrating artificial intelligence and data analytics into content creation and brand management. The company offers a range of services designed to support creators, artists, and businesses in developing, managing, and optimizing their digital presence across various platforms, including customized graphic and posts, short videos, and editorial calendars aligned with brand goals.

Share on Social Networks: